What is Fournier’s gangrene, the rare serious adverse event reported with the empagliflozin component of Synjardy?

Fournier’s gangrene, reported with Synjardy’s empagliflozin component, is necrotising fasciitis of the perineum, a rare, serious and potentially life-threatening event requiring urgent surgical intervention and antibiotic treatment.